Salud financiera de hoja de balance de Eurazeo

Salud financiera controles de criterios 3/6

Eurazeo tiene unos fondos propios totales de €8.4B y una deuda total de €613.9M, lo que sitúa su ratio deuda/fondos propios en 7.3%. Sus activos y pasivos totales son €9.5B y €1.1B respectivamente. Eurazeo El EBIT de la empresa es de €1.2B, por lo que su ratio de cobertura de intereses es de 5.3. Su tesorería e inversiones a corto plazo ascienden a €151.0M.

Información clave

10.8%

Ratio deuda-patrimonio

€903.80m

Deuda

Ratio de cobertura de intereses	1.5x
Efectivo	€151.98m
Patrimonio	€8.35b
Total pasivo	€1.41b
Activos totales	€9.77b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: EUQLos activos a corto plazo (€461.4M) no cubren sus pasivos a corto plazo (€882.8M).

Pasivo a largo plazo: EUQLos activos a corto plazo (€461.4M) superan a sus pasivos a largo plazo (€225.1M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: EUQ(5.5%) se considera satisfactoria.

Reducción de la deuda: EUQ ha pasado de 52.8% a 7.3% en los últimos 5 años.

Cobertura de la deuda: EUQ's operating cash flow es negativo, por lo que la deuda no está bien cubierta.

Cobertura de intereses: EUQLos pagos de intereses de su deuda no están bien cubiertos por el EBIT (1.5x cobertura).

Hoja de balance

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de Eurazeo

Salud financiera controles de criterios 3/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

New major risk - Revenue and earnings growth

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Upcoming dividend of €2.20 per share at 3.3% yield

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Eurazeo SE Announces Its Intention to Resume Distribution

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

New 90-day high: €62.80

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

New 90-day high: €59.80

New 90-day high: €56.85

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

New 90-day high: €55.90

Croda International Plc (LSE:CRDA) completed the acquisition of Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others.

Croda International Plc (LSE:CRDA) agreed to acquire Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others for €820 million.

New 90-day high: €49.82

New 90-day low: €42.94

Hippocrates Holding Draws Up Shortlist of Four for Italy Pharmacy Network

Eurazeo Seeks to Buy Questel

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Volkswagen AG has entered into an agreement to sell Europcar International SA to Eurazeo SA for €3.32 billion.

Eurazeo Appoints Sophie Flak to Its Executive Committee

Eurazeo Reportedly in Negotiations to Take Majority Stake in EasyVista

Eurazeo SE (ENXTPA:RF) entered into an agreement to acquire of remaining 20% stake in Idinvest Partners SA from Christophe Bavière, Benoist Grossmann and their partners.

Eurazeo SE (ENXTPA:RF) completed the acquisition of 25% stake in MCH.

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera